Media Report - Novartis Halts Studies for New Therapy After Patient Deaths
TL;DR
AI-generated
Novartis stopped studies for a new therapy for autoimmune and neurological diseases at the end of August. This is due to three deaths from a severe immune reaction in study participants, a known risk of the novel treatment.
Source: deutschlandfunk.de
Discussion
Log in to join the discussion.
No comments yet. Be the first!